Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D'Erasmo

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal of the American Heart Association|September 21, 2020
Association of Hypertriglyceridemia with All-Cause Mortality and Atherosclerotic Cardiovascular Events in a Low-Risk Italian Population: The TG-REAL Retrospective Cohort AnalysisMarcello Arca, Chiara Veronesi, Laura D'Erasmo, et al.
Atherosclerosis Plus|January 16, 2023
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profileMaria Giovanna Lupo, Diletta Arcidiacono, Alice Zaramella, et al.
Journal of Clinical Lipidology|July 23, 2017
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemiaAlessia Di Costanzo, Enza Di Leo, Davide Noto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2026
Low Cholesterol due to APOB Variants: Exploring the Balance Between Liver and Cardiovascular RiskAlessia Di Costanzo, Ilaria Pirona, Silvia Buonaiuto, et al.
Drugs|March 19, 2025
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New QuestionsDaniele Tramontano, Simone Bini, Carlo Maiorca, et al.
Diabetes/Metabolism Research and Reviews|June 20, 2020
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjectsRoberto Scicali, Philippe Giral, Laura D'Erasmo, et al.
Drugs|May 8, 2025
Lipid-Lowering Therapy and Cardiovascular Prevention in ElderlyFrancesco Baratta, Federica Moscucci, Ilaria Lospinuso, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 29, 2020
Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapiesArturo Cesaro, Alessandra Schiavo, Elisabetta Moscarella, et al.
European Journal of Internal Medicine|January 20, 2024
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countriesAsiiat Alieva, Alessia Di Costanzo, Marta Gazzotti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 2, 2018
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experienceSimona Sperlongano, Felice Gragnano, Francesco Natale, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of the American Heart Association|September 21, 2020
Association of Hypertriglyceridemia with All-Cause Mortality and Atherosclerotic Cardiovascular Events in a Low-Risk Italian Population: The TG-REAL Retrospective Cohort AnalysisMarcello Arca, Chiara Veronesi, Laura D'Erasmo, et al.
Atherosclerosis Plus|January 16, 2023
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: Analysis on cytokines and lipid profileMaria Giovanna Lupo, Diletta Arcidiacono, Alice Zaramella, et al.
Journal of Clinical Lipidology|July 23, 2017
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemiaAlessia Di Costanzo, Enza Di Leo, Davide Noto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2026
Low Cholesterol due to APOB Variants: Exploring the Balance Between Liver and Cardiovascular RiskAlessia Di Costanzo, Ilaria Pirona, Silvia Buonaiuto, et al.
Drugs|March 19, 2025
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New QuestionsDaniele Tramontano, Simone Bini, Carlo Maiorca, et al.
Diabetes/Metabolism Research and Reviews|June 20, 2020
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjectsRoberto Scicali, Philippe Giral, Laura D'Erasmo, et al.
Drugs|May 8, 2025
Lipid-Lowering Therapy and Cardiovascular Prevention in ElderlyFrancesco Baratta, Federica Moscucci, Ilaria Lospinuso, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 29, 2020
Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapiesArturo Cesaro, Alessandra Schiavo, Elisabetta Moscarella, et al.
European Journal of Internal Medicine|January 20, 2024
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countriesAsiiat Alieva, Alessia Di Costanzo, Marta Gazzotti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 2, 2018
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experienceSimona Sperlongano, Felice Gragnano, Francesco Natale, et al.
Pageof 8